Search results for "Immunocompromised"

showing 8 items of 98 documents

Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies

2021

AbstractThere is evidence of reduced SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies. We hypothesized that tumor and treatment-related immunosuppression can be depicted in peripheral blood, and that immune profiling prior to vaccination can help predict immunogenicity. We performed a comprehensive immunological characterization of 83 hematological patients before vaccination and measured IgM, IgG, and IgA antibody response to four viral antigens at day +7 after second-dose COVID-19 vaccination using multidimensional and computational flow cytometry. Health care practitioners of similar age were the control group (n = 102). Forty-four out of 59 immune cell types …

AdultAged 80 and overMaleHaematological cancerCOVID-19 VaccinesSARS-CoV-2COVID-19Vaccine EfficacyNeoplasms. Tumors. Oncology. Including cancer and carcinogenslymphomaHematologyMiddle Agedhematologic malignancieArticleImmunocompromised HostmyelomaOncologyHematologic NeoplasmsHumansTumour immunologyFemaleSars-cov-BiomarkersRC254-282AgedBlood Cancer Journal
researchProduct

Differential performance of a specialist and two generalist herbivores and their parasitoids on Plantago lanceolata

2011

The ability to cope with plant defense chemicals differs between specialist and generalist species. In this study, we examined the effects of the concentration of the two main iridoid glycosides (IGs) in Plantago lanceolata, aucubin and catalpol, on the performance of a specialist and two generalist herbivores and their respective endoparasitoids. Development of the specialist herbivore Melitaea cinxia was unaffected by the total leaf IG concentration in its host plant. By contrast, the generalist herbivores Spodoptera exigua and Chrysodeixis chalcites showed delayed larval and pupal development on plant genotypes with high leaf IG concentrations, respectively. This result is in line with t…

0106 biological sciencesChrysodeixis chalcitesHyposoter didymatorIridoid GlucosidesSpodopteraGeneralist and specialist species010603 evolutionary biology01 natural sciencesMelitaea cinxiaBiochemistryArticlePheromonesParasitoidHost-Parasite InteractionsMultitrophic interactionsSpodoptera exiguaBotanyPlant defense against herbivoryCotesia marginiventrisAnimalsCotesia melitaearumPlantagoEcology Evolution Behavior and Systematics2. Zero hungerImmunocompromised hostHerbivorePlantagobiologyHost (biology)fungiIridoid glycosidesfood and beveragesGeneral MedicineFeeding Behaviorbiology.organism_classificationAdaptation PhysiologicalHymenopteraChrysodeixis chalcitesPlant Leaves010602 entomologyMelitaeaLarvaChemical defensePlants EdibleButterflies
researchProduct

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

2014

The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past decade by the increasing use of immunomodulators, mainly azathioprine (AZA)/6-mercaptopurine (6-MP) and methotrexate (MTX), together with the advent of biological therapy. Immunomodulators are being used more often and earlier in the course of the disease.1 The introduction of biologic agents, especially inhibitors of the key proinflammatory cytokine, tumor necrosis factor alpha (TNF-α) initiated a new therapeutic era, whose use has grown continuously since their introduction in 1998.2 With such immunomodulation, the potential for opportunistic infection is a key safety concern for patients with IBD. Opp…

Adultmedicine.medical_specialtyEvidence-based practiceAdolescentOpportunistic infectionSettore MED/12 - GASTROENTEROLOGIAMEDLINEAzathioprineHIV InfectionsSettore MED/17 - MALATTIE INFETTIVEInflammatory bowel diseaseInflammatory bowel diseaseImmunocompromised HostYoung AdultRisk FactorsInfluenza HumanmedicineParasitic DiseasesHumansOpportunistic infectionsIntensive care medicineECCO guidelinesIrritable bowel syndromebusiness.industryPapillomavirus InfectionsGastroenterologyAge FactorsGeneral MedicineHerpesviridae InfectionsMiddle Agedmedicine.diseaseHepatitis BInflammatory Bowel DiseasesHepatitis CVaccinationMycosesInfectious disease (medical specialty)ImmunologyHuman medicinebusinessmedicine.drug
researchProduct

S3 guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 1

2019

Epicutaneous patch testing is the diagnostic standard for the detection of allergic contact dermatitis. The present guidelines are aimed at residents and board-certified physicians in the fields of dermatology and allergology as well as other medical specialties involved in establishing the indication for patch testing and its execution in patients with contact dermatitis and other forms of delayed-type hypersensitivity. The target audience also includes other health care providers and insurance funds. Based on a systematic literature search and a formal consensus process (S3), the guidelines were developed by dermatologists in collaboration with pediatricians, occupational medicine physici…

Occupational Medicinemedicine.medical_specialtyConsensusMEDLINETarget audienceGuidelines as TopicDermatologyPatch testingOccupational medicineImmunocompromised Host030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePregnancyHealth caremedicineHumansHypersensitivity DelayedPediatriciansChildAllergic contact dermatitisbusiness.industryAllergensPatch Testsmedicine.diseaseTest (assessment)Family medicineDermatitis Allergic ContactFemaleNursing StaffbusinessContact dermatitisDermatologistsJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Milker's nodule: an occupational infection and threat to the immunocompromised

2017

Milker's nodule virus, also called paravaccinia virus is a DNA virus of the parapoxvirus genus transmitted from infected cows to humans. It results from contact with cattle, cattle byproducts, or fomites. Classified as an occupational disorder, those at risk of exposure include farmers, butchers, and agricultural tourists. The viral infection begins 5-15 days after inoculation as an erythematous-purple, round nodule with a clear depressed center, and a surrounding erythematous ring. While familiar to those in farming communities, the presence of the nodule may be concerning to others, particularly the immunosuppressed. Milker's nodules are self-limited in immunocompetent individuals and hea…

0301 basic medicinePoxviridae InfectionsDermatologyDiseaseAntiviral AgentsParavaccinia virusVirusDiagnosis DifferentialImmunocompromised Host030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineIdoxuridineZoonosesAnimalsHumansMedicineErythema multiformeImiquimodbiologybusiness.industryNodule (medicine)medicine.diseasebiology.organism_classificationVirologyOccupational Diseases030104 developmental biologyInfectious DiseasesImmunologyAminoquinolinesParapoxvirusMilker's noduleImmunocompetencemedicine.symptombusinessImmunocompetenceJournal of the European Academy of Dermatology and Venereology
researchProduct

Reconstruction of critical-size mandibular defects in immunoincompetent rats with human adipose-derived stromal cells

2013

In patients with bony defects, autologous bone grafts are the "gold standard" for reconstruction. In children, autologous bone harvesting is limited but tissue engineering offers an alternative. Next to bone marrow, adipose tissue is a source of mesenchymal stromal cells, and adipose-derived stromal cells (ADSC) can differentiate into osteocytes. The aim of this study was to evaluate the efficacy of bioactive implants (ADSC in fibrin glue) for repair of critical-size mandibular defects in athymic rats. Human adult ADSC embedded in fibrin glue were implanted into a critical-size defect in the rat mandible and their efficacy was compared to those of protected bone healing (pbh), autologous bo…

AdultMalePathologymedicine.medical_specialtyStromal cellAdipose tissueFibrin Tissue AdhesiveBone healingOsteocytesImmunocompromised HostRandom AllocationRats NudeTissue engineeringOsteogenesisImage Processing Computer-AssistedAnimalsHumansMedicineMandibular DiseasesIn patientAutograftsFibrin glueWound HealingBone TransplantationTissue EngineeringTissue Scaffoldsbusiness.industryMesenchymal stem cellMesenchymal Stem CellsX-Ray MicrotomographyAnatomyRatsmedicine.anatomical_structureAdipose TissueOtorhinolaryngologySurgeryBone marrowMandibular ReconstructionOral SurgeryTomography X-Ray ComputedbusinessJournal of Cranio-Maxillofacial Surgery
researchProduct

Determinants of influenza vaccination among solid organ transplant recipients attending Sicilian reference center

2016

Among solid organ transplant recipients, influenza infection is commonly associated with higher morbidity and mortality than immunocompetent hosts. Therefore, in these subjects influenza vaccination is of paramount importance. The main objective of the study was to assess compliance to vaccination and analyze factors associated with influenza vaccination of solid organ transplant recipients admitted to the Sicilian solid organ transplant Reference Center IRCCS-ISMETT in Palermo during 2014–2015 influenza season. Thirty one (37.8%) out of 82 solid organ transplant recipients were vaccinated against influenza. The main reason for vaccination refusal was fear of adverse reaction (n = 16, 31.4%…

AdultMale0301 basic medicinemedicine.medical_specialtyMultivariate analysis030106 microbiologyImmunologyTransplantsInfluenza seasondeterminantSettore MED/42 - Igiene Generale E Applicatavaccination uptake03 medical and health sciences0302 clinical medicinehealthcare workerInternal medicinevaccineInfluenza HumanmedicineHumansImmunology and Allergy030212 general & internal medicinecounselling; determinants; healthcare workers; immunization factors; immunocompromised; influenza; pneumococcus; solid organ transplant; vaccination uptake; vaccine; Immunology and Allergy; Immunology; PharmacologyAdverse effectSicilyPharmacologyimmunization factorbusiness.industrypneumococcuVaccinationsolid organ transplantMiddle AgedVaccine efficacyResearch PapersTransplant RecipientsVaccinationVaccination RefusalcounsellingimmunocompromisedInfluenza VaccinesImmunologyFemaleSolid organ transplantationbusinessinfluenza
researchProduct

Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients

2016

Background Invasive fungal infections are important causes of morbidity and mortality among critically ill patients. Early institution of antifungal therapy is pivotal for mortality reduction. Starting a targeted antifungal therapy after culture positivity and fungi identification requires a long time. Therefore, alternative strategies (globally defined as 'untargeted antifungal treatments') for antifungal therapy institution in patients without proven microbiological evidence of fungal infections have been discussed by international guidelines. This review was originally published in 2006 and updated in 2016. This updated review provides additional evidence for the clinician dealing with s…

Adultmedicine.medical_specialtyAntifungal drugMycoseintensive care medicinelaw.invention03 medical and health sciencesImmunocompromised Hostcritically ill patient0302 clinical medicineRandomized controlled triallawInternal medicineAmphotericin BmedicineHumansAntifungal AgentPharmacology (medical)030212 general & internal medicineMED/41 - ANESTESIOLOGIAIntensive care medicineFluconazoleFluconazole [therapeutic use]Randomized Controlled Trials as Topicbusiness.industryfungal infectionMicafungin030208 emergency & critical care medicinePublication biasMycoses [mortalityClinical trialCritical Illness [mortality]; Amphotericin B [therapeutic use]; Antifungal Agents [therapeutic use]; Fluconazole [therapeutic use]; Immunocompromised Host; Mycoses [mortality; prevention & control]; Randomized Controlled Trials as Topic; Adult; HumansAntifungal Agents [therapeutic use]prevention & control]Relative riskMeta-analysisAmphotericin B [therapeutic use]AnidulafunginCritical IllneCritical Illness [mortality]businessmedicine.drugHuman
researchProduct